The use of gastric acid-suppressive agents, such as proton pump inhibitors (PPIs) and histamine type-2 receptor antagonists (H2RAs) may aggravate the risk of dementia among patients with upper gastrointestinal disease, a recent Taiwan study has found.
Stroke survivors treated with endovascular therapy have a more favourable quality of life—including better mobility, increased social life, superior cognition, and less depression—than those who received medical therapy alone, according to a study.
Individuals who frequently binge on alcohol do not appear to be at increased risk of developing ischaemic heart disease (IHD) and stroke as compared with people who drink the same quantity of alcohol over time, a study has found.
The standard combination therapy against paediatric migraine—consisting of a combination of parenteral medications—appears to yield moderate pain relief, which persists up to 1 week after administration, a new study has found.
The phase III OPTIMUM (Oral Ponesimod Versus Teriflunomide In Relapsing Multiple Sclerosis) study shows that ponesimod is superior to teriflunomide in reducing annualized relapse rate (ARR), fatigue, MRI activity, and brain volume loss in relapsing multiple sclerosis (RMS).